Gut microbial bile and amino acid metabolism associate with peanut oral immunotherapy failure
Abstract Peanut Oral Immunotherapy (POIT) holds promise for remission of peanut allergy, though treatment is protracted and successful in only a subset of patients. Because the gut microbiome has been linked to food allergy, we sought to identify fecal predictors of POIT efficacy and mechanistic ins...
Saved in:
| Main Authors: | Mustafa Özçam, Din L. Lin, Chhedi L. Gupta, Allison Li, J. Carlos Gomez, Lisa M. Wheatley, Carolyn H. Baloh, Srinath Sanda, Stacie M. Jones, Susan V. Lynch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-61161-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Immunotherapy with Standardized Peanut Extract: A Game-Changer for Peanut Allergy
by: Edoardo Cavaglià, et al.
Published: (2025-04-01) -
Increased dietary protein stimulates amino acid catabolism via the gut microbiota and secondary bile acid production
by: Sandra Tobón-Cornejo, et al.
Published: (2025-12-01) -
Targeted immunotherapy approaches for intraductal papillary neoplasm of the bile duct
by: Bahareh Sadri, et al.
Published: (2024-06-01) -
The Diagnostic Value of Bile Acids and Amino Acids in Differentiating Acute Coronary Syndromes
by: Yu Q, et al.
Published: (2025-01-01) -
New Plants for Florida: Peanut
by: Don Maynard, et al.
Published: (2003-08-01)